Search Results 271-280 of 16314 for nivolumab

  1. Publications - Elisabeth I. Heath, M.D. - Mayo Clinic

    ... nivolumab in patients with metastatic castration-resistant prostate cancer. Invest New Drugs. 2024 Dec; 42 (6):675-684 Epub 2024 Nov 06. View PubMed; Clements ...

  2. Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer - Mayo Clinic

    ... nivolumab, as well as PD-L1 targeted antibodies such as durvalumab; these agents may have been administered as part of a clinical trial; Cohort 2 (colorectal ...

  3. Where we are with gastric and esophageal cancers - Mayo Clinic

    Similarly, the U.S. FDA approved the combination of chemotherapy with another checkpoint inhibitor, nivolumab, in metastatic gastric adenocarcinoma. The ...

  4. Liver Cancer Clinical Trials - Mayo Clinic Research

    This study will investigate if nivolumab will improve recurrence-free ... Nivolumab) in < 14="">. The secondary objective of this study is to assess the ...

  5. A Study to Evaluate Exemestane in Post-Menopausal Women with Non-Small Cell Lung Cancer (NSCLC) - Mayo Clinic

    ... nivolumab). NOTE: Pathology reports documenting the diagnosis of NSCLC are required to be reviewed to confirm outside diagnosis. Sufficient tumor tissue ...

  6. Cancer Treatment! Clinical Trials - Mayo Clinic Research

    This study aims to identify candidate High Grade Serous Cancer (HGSC) early detection and chemotherapy treatment response biomarkers. For the purpose of this ...

  7. Gastroenterology and Hepatology - Clinical trials

    In-home Versus In-Clinic Subcutaneous Nivolumab Administration through Connected and Remote Cancer CARE Beyond Walls. Jacksonville, Fla. The purpose of this ...

  8. Digital Remote Monitoring of ICI Therapy - Mayo Clinic

    Adults with the diagnosis of skin cancer/melanoma undergoing dual ICI therapy with ipilimumab/nivolumab (IPI/Nivo) as part of regular clinical practice.

  9. Mayo Clinic Q and A: Treatment for liver cancer

    The U.S. Food and Drug Administration recently approved a form of immunotherapy with a drug called nivolumab for liver cancer. Immunotherapy works by ...

  10. A Trial of TTI-621 for Patients With Hematologic Malignancies and Selected Solid Tumors - Mayo Clinic

    Patients with cHL should have failed at least one checkpoint inhibitor therapy before enrolling to the nivolumab combination cohort. Peripheral T-cell ...